Distribution of lactoferrin and 60/65 kDa heat shock protein in normal and inflamed human intestine and liver

Gut

Volumn 38, Issue 1, 1996, Pages 135-140

  Peen, E ^a,b   Enestrom S ^c   Skogh, T ^a,c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmune disease; Inflammation; Lactoferrin; Mycobacterial heat shock protein 65

Indexed keywords

HEAT SHOCK PROTEIN; LACTOFERRIN;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ETIOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS;

EID: 0030053325     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.1.135     Document Type: Article

References (27)

1. Sorensen M, Sorensen SPL. The proteins in whey. Comptes Rendus des Travaux du Laboratoire Carlsberg. Série Chemique 1939 23: 55-99.
2. Blanc B, Isliker H. Isolement et caractérisation de la protéine rouge sidérophile du lait maternel: la lactotransferrine. Bull Chim Soc Biol 1961; 43: 929-43.
3. Matsumota A, Yoshima H, Takasaki S, Kobafa A. Structural study of the sugar chains of human lactoferrin. Finding of four novel complex-type aspargine-linked sugar chains. J Biochem 1982; 91: 143-55.
4. Woodhouse LR, Lönnerdal B. Quantification of the major whey proteins in human milk, and development of a technique to isolate minor whey proteins. Nutr Res 1988; 8: 853-64.
5. Masson PL, Heremans JF. New data on lactoferrin, the iron-binding protein of secretions. In: Peters H, eds. Protides of the biological fluids. Oxford: Pergamon Press, 1968; 633-8.
6. Hekman A, Rümke P. The antigens of human seminal plasma (with special reference to lactoferrin as a spermatozoa-coating antigen). In: Peters H, eds. Protides of the biological fluids. Oxford: Pergamon Press, 1968; 549-52.
7. Iyer S, Lönnerdal B. Lactoferrin, lactoferrin receptors and iron metabolism. Eur J Clin Nutr 1993; 47: 232-41.
8. Arnold RR, Cole MF, McGhee JR. A bactericidal effect for human lactoferrin. Science 1977; 197: 263-5.
9. Arnold RR, Russel JE, Champion WJ, Brewer M, Gauthier JJ. Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation. Infect Immun 1982; 35: 792.
10. Dionysius DA, Grieve PA, Milne JM. Forms of lactoferrin: their antibacterial effect on enteropathogenic Escherichia coli. J Dairy Sci 1993; 76: 2597-606.
11. Kijlstra A, Jeurissen SHM. Modulation of classical C3 convertase of complement by tear lactoferrin. Immunology 1982; 47: 263-70.
12. Kuizenga A, van Haeringen NJ, Kijlstra A. Inhibition of hydroxyl radical formation by human tears. Invest Ophthalmol Vis Sci 1987; 28: 305-13.
13. Britigan BE, Hassett DJ, Rosen GM, Hamill DR, Cohen MS. Neutrophil degranulation inhibits potential hydroxyl radical formation. Biochem J 1989; 264: 447-55.
14. Cohen MS, Mao J, Rasmussen GT, Serody JS, Britigan BE. Interaction of lactoferrin and lipopolysaccharide (LPS): effects on the antioxidant property of lactoferrin and the ability of LPS to prime human neutrophils for enhanced superoxide formation. J Infect Dis 1992; 166: 1375-8.
15. Cramer E, Pryzwansky KB, Villeval JL, Testa U, Breton-Gorius J. Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold. Blood 1985; 65: 423-32.
16. Leffel MS, Spitznagel JK. Fate of human lactoferrin and myeloperoxidase in phagocytosing human neutrophils: effects of immunoglobulin G subclasses and immune complexes coated with latex beads. Infect Immunity 1975; 12: 813-20.
17. van Snick JL, Masson PL, Heremans JF. The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med 1974; 140: 1068-84.
18. Lash JA, Coates TD, Lafuze J, Baehner RL, Boxer LA. Plasma lactoferrin reflects granulocyte activation in vivo. Blood 1983; 61: 885-8.
19. Lee GR. The anemia of chronic disease. Semin Hematol 1983; 20: 61-80.
20. Boxer LA, Björkstén B, Björk J, Yang HH, Allen JM, Baehner RL. Neutropenia induced by systemic infusion of lactoferrin. J Lab Clin Med 1982; 99: 866-72.
21. Oseas R, Yang HH, Baehner RL, Boxer LA. Lactoferrin: a promotor of polymorphonuclear leukocyte adhesiveness. Blood 1981; 57: 939-45.
22. Kurose I, Yamada T, Wolf R, Granger DN. P-selectin-dependent leukocyte recruitment and intestinal mucosal injury induced by lactoferrin. J Leukoc Biol 1994; 55: 771-7.
23. Wang CS, Chan WY, Kloer HU. Comparative studies on the chemical and immunochemical properties of human milk, human pancreatic juice and bovine milk lactoferrin. Comp Biochem Physiol 1984; 78B: 575-80.
24. Peen E, Almer S, Bodemar G, Rydén B-O, Sjölin C, Tejle K, et al. Anti-lactoferrin antibodies and other types of ANCA in Crohn's disease, ulcerative colitis, and primary sclerosing cholangitis. Gut 1993; 34: 56-62.
25. Coremans IBM, Hagen EC, van der Woude FJ, van der Voort EAM, Kleijburg-van der Keur C, Breedveld FC. Anti-lactoferrin antibodies in patients with rheumatoid arthritis and vasculitis. Arthritis Rheum 1992; 35: 1466-75.
26. Ellenbroek PM, Oudkerk Pool M, Ridwan BU, Dolman KM, von Blomberg BME, von dem Borne AEGKr, et al. Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol 1994; 47: 257-62.
27. Mulder AHL, Broekroelofs J, Horst G, Limburg PC, Nelis GF, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease; characterization and clinical correlations. Clin Exp Immunol 1994; 95: 490-7.